1. Home >
  2. Ixo Private Equity and Bpifrance Investissement Acquire Baobag

M&A Deal Summary

Ixo Private Equity and Bpifrance Investissement Acquire Baobag

On January 1, 2016, private equity firm Ixo Private Equity and Bpifrance Investissement acquired packaging company Baobag

Acquisition Highlights
  • This is Ixo Private Equity’s 1st and Bpifrance Investissement’s 1st transaction in the Packaging sector.
  • This is Ixo Private Equity’s 15th and Bpifrance Investissement’s 10th transaction in France.
Investment Fate
  • Baobag was sold to a consortium of financial buyers in 2021.

M&A Deal Summary
Date 2016-01-01
Target Baobag
Sector Packaging
Buyer(s) Ixo Private Equity
Bpifrance Investissement
Deal Type Buyout (LBO, MBO, MBI)

Target

Baobag

Floirac, France
Baobag is a pure distributor of Flexible Intermediate Bulk Containers (“FIBC”), commonly known as big bags. The company operates throughout the value chain, including design, sourcing, transportation, and storage. Baobag was formed in 2007 and is based in Floirac, France.

Search 204,883 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Ixo Private Equity

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2002
PE ASSETS 800M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Ixo Private Equity is a private investment firm focused on acquiring and investing in companies at all stages, including venture, growth, and buyout. The Firm's buyout group does not have any sector preferences and looks to invest €1 to €30 million. Ixo's geographic preference is for opportunities throughout Western Europe. Ixo Private Equity was formed in 2002 and is based in Toulouse, France.

DEAL STATS #
Overall 17 of 52
Sector (Packaging) 1 of 1
Type (Buyout (LBO, MBO, MBI)) 5 of 10
Country (France) 15 of 48
Year (2016) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-01 GamaMabs Pharma

Toulouse, France

GamaMabs Pharma is an immuno-oncology biotechnology company, provides the development of optimized antibodies targeting AMHR2 for the treatment of cancer. The company develops low-fucose EMABling® antibodies (license granted by LFB) with increased tumor cell killing properties through a breakthrough activation of immune cells. GamaMabs Pharma was founded in 2013 and is based in Toulouse, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-18 Neotec

Bressols, France

Neotec specializes in design and manufacture of sub-assemblies, equipment, chassis and vehicle transmission components for industrial applications, particularly railway applications. Neotec was founded in 1991 and is based in Bressols, France.

Buy -
Buyer

Bpifrance Investissement

Category Private Equity Firm
Type Sector Agnostic
DESCRIPTION

DEAL STATS #
Overall 10 of 94
Sector (Packaging) 1 of 3
Type (Buyout (LBO, MBO, MBI)) 3 of 26
Country (France) 10 of 93
Year (2016) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-03 JRI

Île-de-France, France

JRI is specialized in the manufacturing and distribution of systems designed to measure and monitor physical units (temperature, humidity, pressure) primarily for the healthcare and agribusiness sectors. JRI also offers its clients a broad range of metrology services. JRI is based in Île-de-France, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-27 Looping

Saint-Malo, France

Looping is a pan-European leisure park operator that owns and operates 18 local and regional leisure parks, including theme parks, waterparks, wildlife parks, and aquariums, attracting over six million visitors a year. The group’s parks span eight European countries, including France, the UK, Spain, Switzerland, the Netherlands, Croatia, Germany, and Portugal. Looping was founded in 2011 and is based in Saint-Malo, France.

Buy -
Mergr

Product

Company

Legal